CORD-19:c738a511a9c18e7e831b40f1ec3605fe4cdeb6d1 / 7050-7255 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T42","span":{"begin":0,"end":205},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"For patients with ER+ breast cancers, either DCIS or invasive, who may otherwise experience a delay or interruption in treatment, we support the prompt initiation of endocrine therapy among those eligible."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T42","span":{"begin":0,"end":205},"obj":"Sentence"}],"text":"For patients with ER+ breast cancers, either DCIS or invasive, who may otherwise experience a delay or interruption in treatment, we support the prompt initiation of endocrine therapy among those eligible."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T18","span":{"begin":22,"end":36},"obj":"Phenotype"}],"attributes":[{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0003002"}],"text":"For patients with ER+ breast cancers, either DCIS or invasive, who may otherwise experience a delay or interruption in treatment, we support the prompt initiation of endocrine therapy among those eligible."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T23","span":{"begin":22,"end":28},"obj":"Body_part"}],"attributes":[{"id":"A23","pred":"uberon_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"For patients with ER+ breast cancers, either DCIS or invasive, who may otherwise experience a delay or interruption in treatment, we support the prompt initiation of endocrine therapy among those eligible."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T49","span":{"begin":18,"end":36},"obj":"Disease"},{"id":"T50","span":{"begin":45,"end":49},"obj":"Disease"},{"id":"T40936","span":{"begin":18,"end":36},"obj":"Disease"},{"id":"T23851","span":{"begin":45,"end":49},"obj":"Disease"}],"attributes":[{"id":"A49","pred":"mondo_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/MONDO_0006512"},{"id":"A50","pred":"mondo_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/MONDO_0005023"},{"id":"A15543","pred":"mondo_id","subj":"T40936","obj":"http://purl.obolibrary.org/obo/MONDO_0006512"},{"id":"A96335","pred":"mondo_id","subj":"T23851","obj":"http://purl.obolibrary.org/obo/MONDO_0005023"}],"text":"For patients with ER+ breast cancers, either DCIS or invasive, who may otherwise experience a delay or interruption in treatment, we support the prompt initiation of endocrine therapy among those eligible."}